Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02832622 · ClinicalTrials.gov registry record
MultiPoint Pacing™ Post Market Study
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 2,169
- Enrollment target
NCT02832622: Completed study, sponsored by Abbott Medical Devices.
NCT02832622 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 2,169 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02832622 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 2,169 participants
- Enrollment target
Study Summary
This is a prospective, multicenter, non-randomized registry/observational study. The study will enroll up to 2,000 patients with successful St. Jude Medical (SJM) Cardiac Resynchronization Therapy (CRT) MP device implant from up to 140 centers undergoing CRT implantation.
Primary Outcome
The CCS has 4 components: New York Heart Association (NYHA) functional classification, Patient Global Assessment (PGA), heart failure (HF) events, cardiovascular death. NYHA Class ranges from Class I (least severe) to Class IV (most severe); possible PGA responses are "markedly worse", "moderately worse", "slightly worse", "no change", "slightly better", "moderately better, "markedly better". CCS components were used to classify or score subjects as "IMPROVED" (at least one-class improvement in
Interventions
- DEVICE MPP
- DEVICE BiV/MPP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,169 participants |
| Start Date | 2016-07 |
| Est. Completion | 2019-07-15 |
What the finished NCT02832622 record still lists
NCT02832622 is an observational study that tracks outcomes without assigning an intervention. Its 2,169 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which MPP is the first listed.
NCT02832622 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02832622 about?
NCT02832622 is a clinical study titled "MultiPoint Pacing™ Post Market Study". This is a prospective, multicenter, non-randomized registry/observational study. The study will enroll up to 2,000 patients with successful St. Jude Medical (SJM) Cardiac Resynchronization Therapy (CRT) MP device implant from up to 140 centers undergoing CRT implantation.
What is the current status of trial NCT02832622?
This trial is currently completed. The enrollment target is 2,169 participants. The study started on 2016-07. Estimated completion is 2019-07-15.
What interventions are being tested in trial NCT02832622?
The interventions under investigation include: MPP (DEVICE), BiV/MPP (DEVICE).
Who is sponsoring clinical trial NCT02832622?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05742178 · 2,160 participants · NA
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation
- NCT05917652 · 2,183 participants
The Actuate-CBC Study
- NCT06783335 · 2,150 participants
Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure
- NCT05805709 · 2,145 participants · NA
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia